Precision Medicine News and Research

RSS

Focus on single sex threatens to limit impact of research findings, says Tulane endocrinologist

Over the last decade, many drugs that have been pulled from the market due to toxicity were withdrawn because they affected women more than men.

7 Jun 2017

New immunotherapy sends multiple myeloma into remission

Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.

6 Jun 2017

New targeted oral therapy results in durable responses across many kinds of cancer

Scientists may have developed the first targeted, oral, tumor-type agnostic therapy - a cancer medicine that works comparably well across many kinds of cancer, regardless of patient age. In clinical trials of adults and children with 17 different types of advanced cancer, larotrectinib treatment resulted in responses in 76% of patients.

5 Jun 2017

Genetic sequencing could help direct treatment for 72% of advanced cancer patients

A new analysis finds that nearly three-quarters of 500 patients with advanced cancer could be referred to a potential targeted treatment based on the results of a comprehensive analysis of their tumor's genetic landscape.

2 Jun 2017

CLI could be promising technique for assessing tumor margins during breast-conserving surgery

Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

1 Jun 2017

Penn State researchers show possible link between partial meltdown at TMI and thyroid cancers

Penn State College of Medicine researchers have shown, for the first time, a possible correlation between the partial meltdown of the Three Mile Island Nuclear Generating Station and thyroid cancers in the counties surrounding the plant.

1 Jun 2017

Moffitt researchers hope to improve personalized radiation therapy for head and neck cancer patients

Radiation therapy is one of the most common treatments used to fight cancer, with an estimated 500,000 people each year receiving radiation therapy either alone or in combination with other treatments.

31 May 2017

Researchers make significant advance in treatment of bowel cancer

New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.

31 May 2017

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive final Local Coverage Determination to expand Medicare coverage of the Prolaris test.

29 May 2017

New therapeutic approach could save diabetics from amputation by promoting wound healing

Diabetic patients frequently have lesions on their feet that are very difficult to heal due to poor blood circulation. In cases of serious non-healing infections, a decision to amputate could be made. A new therapeutic approach, presented recently in the Journal of Investigative Dermatology by Canadian researchers affiliated with the University of Montreal Hospital Research Centre, could prevent these complications by promoting wound healing.

29 May 2017

Dragon Master Foundation to fund DIPG trial that will make patient data available live in the cloud

Dragon Master Foundation has announced plans to provide $300,000 in funding for the first clinical trial that will make patient data available live in the cloud while the trial is underway.

27 May 2017

Study examines relationship between statin use and heart structure, function

Statins are associated with improved heart structure and function, according to research presented today at EuroCMR 2017. The benefits were above and beyond the cholesterol lowering effect of statins.

26 May 2017

Study finds wearable fitness trackers accurately measure heart rate but not energy expenditure

According to a study published online in the Journal of Personalized Medicine, fitness activity trackers measure heart rates precisely but not the number of calories burned.

25 May 2017

Researchers present promising approach to create virus- and oncogene-free IPSCs

Induced pluripotent stem cells (IPSCs) hold great promise in regenerative medicine, personalized medicine and drug discovery.

24 May 2017

Scientists create graphene-based sensor to predict onset of asthma attacks

Rutgers University-New Brunswick scientists have created a graphene-based sensor that could lead to earlier detection of looming asthma attacks and improve the management of asthma and other respiratory diseases, preventing hospitalizations and deaths.

22 May 2017

EHRA EUROPACE - CARDIOSTIM 2017 to showcase holographic cardiac imaging and other innovations

Holographic cardiac imaging and other innovations will be showcased at the EHRA EUROPACE - CARDIOSTIM 2017 in Vienna, Austria.

18 May 2017

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

The U.S. Food and Drug Administration today expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis.

18 May 2017

IBM and Rensselaer create new research center to develop cognitive tools for health empowerment

IBM and Rensselaer Polytechnic Institute today announced the creation of the new Center for Health Empowerment by Analytics, Learning, and Semantics.

17 May 2017

Scientists develop world's first smartphone app to collect large data for people with MS

What if a single smartphone app could help solve the enigma of multiple sclerosis and move new treatments ahead at lightning speed? That was the bold idea that led Keck Medicine of USC neurologist Daniel Pelletier, MD, professor of neurology at the Keck School of Medicine of USC and division chief of the Neuro-Immunology and USC Multiple Sclerosis Center, to develop myMS, the world's first smartphone app capable of collecting large amounts of clinical, imaging and genetic data for people with MS. Enrollment is now underway for a pilot study of the app.

16 May 2017

Research identifies protein that could help patients respond more positively to epilepsy drug therapies

New research from the University of Liverpool, in collaboration with the Mario Negri Institute in Milan, published today in the Journal of Clinical Investigation, has identified a protein that could help patients with epilepsy respond more positively to drug therapies.